Literature DB >> 28158530

Usefulness of 3D echocardiographic parameters of tricuspid valve morphology to predict residual tricuspid regurgitation after tricuspid annuloplasty.

Hiroto Utsunomiya1, Yuji Itabashi1, Hirotsugu Mihara1, Sayuki Kobayashi1, Michele A De Robertis1, Alfredo Trento1, Takahiro Shiota1.   

Abstract

AIMS: Tricuspid valve (TV) annuloplasty is an effective treatment for tricuspid regurgitation (TR). However, the impact of TV morphology on outcome of TV annuloplasty remains unknown. We sought to investigate the relationship between preoperative TV morphology and residual TR after annuloplasty. METHODS AND
RESULTS: Two-dimensional transthoracic and three-dimensional (3D) transesophageal echocardiography were performed in 97 patients with functional TR before and after surgery. 3D quantitative assessment including annular dimension, tenting height and volume, and lengths and tethering angles of the 3 leaflets was performed. The TV morphological score was derived from the preoperative 3D echocardiography to score a leaflet mobility, leaflet thickening, subvalvular thickening, and calcification. TR severity was determined by the averaged vena contracta measured from the apical and parasternal inflow views. Multivariable analysis revealed that a shorter total leaflet length (P = 0.007), larger tenting volume (P < 0.001), and higher TV morphological score (P < 0.001) were independently associated with residual TR. A TV-Echo score was determined as a sum of points based on receiver operator characteristics analysis: total leaflet length >61.0 mm, 61.0 to 53.5 mm, and <53.5 mm; tenting volume <2.3 mL, 2.3 to 3.5 mL, and >3.5 mL; and TV morphological score <7, 7 to 18, and >18; each variable was associated with 0 and 1 point and 2 points, respectively. The TV-Echo score ≥2 was associated with significant residual TR with a sensitivity of 85.7% and a specificity of 71.0%.
CONCLUSION: In addition to tethering and short length of the leaflets, TV morphological abnormality predicted residual TR after TV annuloplasty. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author 2017. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  3D transesophageal echocardiography; annuloplasty; tricuspid regurgitation

Mesh:

Year:  2017        PMID: 28158530     DOI: 10.1093/ehjci/jew323

Source DB:  PubMed          Journal:  Eur Heart J Cardiovasc Imaging        ISSN: 2047-2404            Impact factor:   6.875


  6 in total

Review 1.  Multi-Modality Imaging in the Evaluation and Treatment of Tricuspid Regurgitation.

Authors:  Samuel M Kim; Harsimran S Singh; Jillian Nati; Jonathan N Ginns
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-08-09

Review 2.  Contemporary review in the multi-modality imaging evaluation and management of tricuspid regurgitation.

Authors:  Tom Kai Ming Wang; Shinya Unai; Bo Xu
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

3.  Three-dimensional transesophageal echocardiographic morphological evaluation of the tricuspid valve.

Authors:  Takumi Kawase; Yosuke Takahashi; Asahiro Ito; Hisako Yoshida; Yosuke Sumii; Kenta Nishiya; Noriaki Kishimoto; Kokoro Yamane; Yoshito Sakon; Akimasa Morisaki; Hiromichi Fujii; Toshihiko Shibata
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-07-09

4.  A Pilot Study on Linking Tissue Mechanics with Load-Dependent Collagen Microstructures in Porcine Tricuspid Valve Leaflets.

Authors:  Luke T Hudson; Samuel V Jett; Katherine E Kramer; Devin W Laurence; Colton J Ross; Rheal A Towner; Ryan Baumwart; Ki Moo Lim; Arshid Mir; Harold M Burkhart; Yi Wu; Chung-Hao Lee
Journal:  Bioengineering (Basel)       Date:  2020-06-18

5.  Three-Dimensional Echocardiography Reveals Extensive Congenital Anterior Tricuspid Valve Prolapse.

Authors:  Kazuki Yoshida; Tai Sekine; Noriko Suzuki-Eguchi; Hiroyuki Watanabe; Yoshio Kobayashi; Goro Matsumiya; Kazuyuki Matsushita
Journal:  CASE (Phila)       Date:  2020-02-12

Review 6.  Multi-Modality Imaging for Interventions in Tricuspid Valve Disease.

Authors:  Federico Fortuni; Kensuke Hirasawa; Jeroen J Bax; Victoria Delgado; Nina Ajmone Marsan
Journal:  Front Cardiovasc Med       Date:  2021-02-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.